Co-Diagnostics, Inc. (NASDAQ:CODX) management will conduct a conference call for 16th November 2020 at 4:30 PM Eastern Time to discuss financial results and companys performance for 3Q20.
The conference call will also be available live on the website www.codiagnostics.com
Earnings Expectation
Co-Diagnostics, Inc. is reporting third quarter earnings results on Monday 16th November 2020, after market close.
The consensus estimates from Thomson Reuters are income of $ 0.63 per share from $ 32.79 million in revenue. For the full year, analysts predict revenues of $ 93.86 million, while looking forward to income of $ 1.83 per share.
Co-Diagnostics, Inc., a molecular diagnostics company, intends to manufacture and sell reagents used for diagnostic tests that function via the detection and/or analysis of nucleic acid molecules. It also intends to sell diagnostic equipment from other manufacturers as self-contained lab systems. The company was founded in 2013 and is headquartered in Salt Lake City, Utah.
